Psyence Historical Income Statement

PBM Stock

USD 3.46 0.05 1.42%

Historical analysis of Psyence Biomedical income statement accounts such as Other Operating Expenses of 1.6 M, Research Development of 990.3 K, Total Operating Expenses of 1.6 M or Interest Expense of 29.1 K can show how well Psyence Biomedical Ltd performed in making a profits. Evaluating Psyence Biomedical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Psyence Biomedical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About Psyence Income Statement Analysis

Psyence Biomedical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Psyence Biomedical shareholders. The income statement also shows Psyence investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Psyence Biomedical Income Statement Chart

Selling General Administrative Selling And Marketing Expenses Research Development Income Before Tax

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Psyence Biomedical income statement and is an important metric when analyzing Psyence Biomedical profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Psyence Biomedical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Psyence Biomedical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Psyence Biomedical income statement Correlations

	Selling General Administrative	Selling And Marketing Expenses	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Depreciation And Amortization	Gross Profit	Ebit	Cost Of Revenue
Selling General Administrative		0.75	0.27	-0.5	-0.66	0.0	-0.5	0.27	-0.67	-0.68	-0.67	-0.83	0.49	0.49	-0.83
Selling And Marketing Expenses	0.75		0.83	-0.91	-0.99	0.46	-0.91	0.83	-0.99	-0.99	-0.99	-0.95	0.94	0.94	-0.95
Other Operating Expenses	0.27	0.83		-0.96	-0.9	0.78	-0.96	1.0	-0.89	-0.89	-0.89	-0.73	0.94	0.94	-0.73
Operating Income	-0.5	-0.91	-0.96		0.96	-0.78	1.0	-0.96	0.96	0.95	0.96	0.89	-0.92	-0.92	0.89
Net Income From Continuing Ops	-0.66	-0.99	-0.9	0.96		-0.57	0.96	-0.9	1.0	1.0	1.0	0.93	-0.96	-0.96	0.93
Research Development	0.0	0.46	0.78	-0.78	-0.57		-0.78	0.78	-0.56	-0.55	-0.56	-0.53	0.53	0.53	-0.53
Ebitda	-0.5	-0.91	-0.96	1.0	0.96	-0.78		-0.96	0.96	0.95	0.96	0.89	-0.92	-0.92	0.89
Total Operating Expenses	0.27	0.83	1.0	-0.96	-0.9	0.78	-0.96		-0.89	-0.89	-0.89	-0.73	0.94	0.94	-0.73
Income Before Tax	-0.67	-0.99	-0.89	0.96	1.0	-0.56	0.96	-0.89		1.0	1.0	0.93	-0.96	-0.96	0.93
Total Other Income Expense Net	-0.68	-0.99	-0.89	0.95	1.0	-0.55	0.95	-0.89	1.0		1.0	0.93	-0.96	-0.96	0.93
Net Income	-0.67	-0.99	-0.89	0.96	1.0	-0.56	0.96	-0.89	1.0	1.0		0.93	-0.96	-0.96	0.93
Depreciation And Amortization	-0.83	-0.95	-0.73	0.89	0.93	-0.53	0.89	-0.73	0.93	0.93	0.93		-0.8	-0.8	1.0
Gross Profit	0.49	0.94	0.94	-0.92	-0.96	0.53	-0.92	0.94	-0.96	-0.96	-0.96	-0.8		1.0	-0.8
Ebit	0.49	0.94	0.94	-0.92	-0.96	0.53	-0.92	0.94	-0.96	-0.96	-0.96	-0.8	1.0		-0.8
Cost Of Revenue	-0.83	-0.95	-0.73	0.89	0.93	-0.53	0.89	-0.73	0.93	0.93	0.93	1.0	-0.8	-0.8

Click cells to compare fundamentals

Psyence Biomedical Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:

How To Invest In Psyence

Details

Is Psyence Stock a good investment?

Details

What is Psyence Biomedical's Net Worth?

Details

Largest Pharmaceutical Products Companies

View

Largest Biotechnology Companies

View

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(7.82)

Return On Assets

(1.26)

The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Psyence Historical Income Statement

About Psyence Income Statement Analysis

Psyence Biomedical Income Statement Chart

Income Before Tax

Psyence Biomedical income statement Correlations

Psyence Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Interest Income	Interest Income
Selling General Administrative	Selling And Marketing Expenses
Total Revenue	Other Operating Expenses
Operating Income	Net Income From Continuing Ops
Research Development	Ebitda
Total Operating Expenses	Income Before Tax
Total Other Income Expense Net	Net Income
Interest Expense	Reconciled Depreciation
Depreciation And Amortization	Gross Profit
Ebit	Cost Of Revenue

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Total Other Income Expense Net	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Total Other Income Expense Net	+ 1.0	Income Before Tax

Net Income	- 0.99	Selling And Marketing Expenses
Total Other Income Expense Net	- 0.99	Selling And Marketing Expenses
Income Before Tax	- 0.99	Selling And Marketing Expenses
Net Income From Continuing Ops	- 0.99	Selling And Marketing Expenses
Ebit	- 0.96	Net Income
Gross Profit	- 0.96	Net Income